The European Investment Bank (EIB) is to provide €15 million to IRBM SpA of Italy to expand research into new vaccines and treatments for SARS-CoV-2 and future coronaviruses. The funding, which runs through to 2024 will increase vaccine production capacity and prepare for future outbreaks of infectious diseases. It comes at a time when vaccine companies elsewhere are also bolstering manufacturing capacity in the wake of the Covid-19 pandemic.
